Pan-cancer analysis indicated that TAP1 expression was positively correlated with immune regulators in the majority of cancer types, particularly BRCA, KIRC, prostate adenocarcinoma (PRAD), testicular cancer (TGCT), thyroid carcinoma (THCA), and UVM. This evidence concerns the gene TAP1 and prostate adenocarcinoma.